Tumor-homing peptides as tools for targeted delivery of payloads to the placenta

Science Advances

Volumn 2, Issue 5, 2016, Pages

  King, Anna ^a,b   Ndifon, Cornelia ^a,b   Lui, Sylvia ^a,b   Widdows, Kate ^a,b   Kotamraju, Venkata R ^c,d   Agemy, Lilach ^c,d,e   Teesalu, Tambet ^c,d,f   Glazier, Jocelyn D ^a,b   Cellesi, Francesco ^a,g,h,i,j   Tirelli, Nicola ^a,e   Aplin, John D ^a,b   Ruoslahti, Erkki ^c,d   Harris, Lynda K ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^g Faculty of Medicine   (Estonia)

^h CEN European Centre for Nanomedicine   (Italy)

ⁱ FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^j POLITECNICO DI MILANO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BINS; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; LIPOSOMES; MAMMALS; NANOPARTICLES; PEPTIDES; TUMORS;

CARBOXYFLUORESCEIN; COATED NANOPARTICLES; FETAL GROWTH; FETAL GROWTH RESTRICTION; HOMING PEPTIDE; INSULIN-LIKE GROWTH FACTOR 2; PROOF OF PRINCIPLES; TARGETED DELIVERY;

TARGETED DRUG DELIVERY;

CALRETICULIN; DRUG CARRIER; LIPOSOME; NANOPARTICLE; PEPTIDE FRAGMENT; PROTEIN BINDING; SMALL INTERFERING RNA; SOMATOMEDIN B;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; MOUSE; PLACENTA; PREGNANCY;

AMINO ACID SEQUENCE; ANIMALS; CALRETICULIN; CELL-DERIVED MICROPARTICLES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIPOSOMES; MICE; NANOPARTICLES; PEPTIDE FRAGMENTS; PLACENTA; PREGNANCY; PROTEIN BINDING; RNA, SMALL INTERFERING;

EID: 84984606315     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1600349     Document Type: Article

References (53)

1. A. P. MacKay, C. J. Berg, H. K. Atrash, Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 97, 533-538 (2001
2. J. Uzan, M. Carbonnel, O. Piconne, R. Asmar, J.-M. Ayoubi, Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc. Health Risk Manag. 7, 467-474 (2011
3. M. L. Chiswick, Intrauterine growth retardation. Br. Med. J. 291, 845-848 (1985
4. C. P. Sibley, M. A. Turner, I. Cetin, P. Ayuk, C. A. R. Boyd, S. W. D'Souza, J. D. Glazier, S. L. Greenwood, T. Jansson, T. Powell, Placental phenotypes of intrauterine growth. Pediatr. Res. 58, 827-832 (2005
5. J. C. P. Kingdom, S. J. Burrell, P. Kaufmann, Pathology and clinical implications of abnormal umbilical artery Doppler waveforms. Ultrasound Obstet. Gynecol. 9, 271-286 (1997
6. P. D. Gluckman, M. A. Hanson, C. Cooper, K. L. Thornburg, Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359, 61-73 (2008
7. L. Doridot, B. Passet, C. Méhats, V. Rigourd, S. Barbaux, A. Ducat, F. Mondon, M. Vilotte, J. Castille, M. Breuiller-Fouché, N. Daniel, F. le Provost, A.-L. Bauchet, V. Baudrie, A. Hertig, C. Buffat, U. Simeoni, G. Germain, J.-L. Vilotte, D. Vaiman, Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 61, 662-668 (2013
8. J. L. Stanley, I. J. Andersson, C. J. Hirt, L. Moore, M. R. Dilworth, A. R. Chade, C. P. Sibley, S. T. Davidge, P. N. Baker, Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction. Biol. Reprod. 87, 1-8 (2012
9. J. L. Stanley, I. J. Andersson, R. Poudel, C. F. Rueda-Clausen, C. P. Sibley, S. T. Davidge, P. N. Baker, Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension 59, 1021-1028 (2012
10. N. M. Fisk, R. Atun, Market failure and the poverty of new drugs in maternal health. PLOS Med. 5, e22 (2008
11. N. M. Fisk, M. McKee, R. Atun, Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop. Med. Int. Health 16, 662-668 (2011
12. W. Arap, R. Pasqualini, E. Ruoslahti, Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377-380 (1998
13. E. Ruoslahti, S. N. Bhatia, M. J. Sailor, Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188, 759-768 (2010
14. D. Hanahan, J. Folkman, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996
15. T. M. Allen, P. R. Cullis, Drug delivery systems: Entering the mainstream. Science 303, 1818-1822 (2004
16. E. Ruoslahti, Specialization of tumour vasculature. Nat. Rev. Cancer 2, 83-90 (2002
17. J. A. Hoffman, E. Giraudo, M. Singh, L. Zhang, M. Inoue, K. Porkka, D. Hanahan, E. Ruoslahti, Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 4, 383-391 (2003
18. L. Agemy, D. Friedmann-Morvinski, V. R. Kotamraju, L. Roth, K. N. Sugahara, O. M. Girard, R. F. Mattrey, I. M. Verma, E. Ruoslahti, Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc. Natl. Acad. Sci. U.S.A. 108, 17450-17455 (2011
19. L. Agemy, V. R. Kotamraju, D. Friedmann-Morvinski, S. Sharma, K. N. Sugahara, E. Ruoslahti, Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. Mol. Ther. 21, 2195-2204 (2013
20. K. N. Sugahara, T. Teesalu, P. P. Karmali, V. R. Kotamraju, L. Agemy, O. M. Girard, D. Hanahan, R. F. Mattrey, E. Ruoslahti, Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16, 510-520 (2009
21. C. Ferretti, L. Bruni, V. Dangles-Marie, A. P. Pecking, D. Bellet, Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum. Reprod. Update 13, 121-141 (2007
22. R. Pijnenborg, L. Vercruysse, M. Hanssens, The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 27, 939-958 (2006
23. J.-H. Park, G. von Maltzahn, L. Zhang, M. P. Schwartz, E. Ruoslahti, S. N. Bhatia, M. J. Sailor, Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv. Mater. 20, 1630-1635 (2008
24. L. Agemy, K. N. Sugahara, V. R. Kotamraju, K. Gujraty, O. M. Girard, Y. Kono, R. F. Mattrey, J.-H. Park, M. J. Sailor, A. I. Jimenez, C. Cativiela, D. Zanuy, F. J. Sayago, C. Aleman, R. Nussinov, E. Ruoslahti, Nanoparticle-induced vascular blockade in human prostate cancer. Blood 116, 2847-2856 (2010
25. M. Constância, M. Hemberger, J. Hughes, W. Dean, A. Ferguson-Smith, R. Fundele, F. Stewart, G. Kelsey, A. Fowden, C. Sibley, W. Reik, Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417, 945-948 (2002
26. K. Forbes, M. Westwood, P. N. Baker, J. D. Aplin, Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am. J. Physiol. Cell Physiol. 294, C1313-C1322 (2008
27. J. C. Charnock, M. R. Dilworth, J. D. Aplin, C. P. Sibley, M. Westwood, I. P. Crocker, The impact of a human IGF-II analogue ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction. Am. J. Physiol. Endocrinol. Metab. 310, E24-E31 (2015
28. K. Yamashita, Y. Yoshioka, K. Higashisaka, K. Mimura, Y. Morishita, M. Nozaki, T. Yoshida, T. Ogura, H. Nabeshi, K. Nagano, Y. Abe, H. Kamada, Y. Monobe, T. Imazawa, H. Aoshima, K. Shishido, Y. Kawai, T. Mayumi, S.-i. Tsunoda, N. Itoh, T. Yoshikawa, I. Yanagihara, S. Saito, Y. Tsutsumi, Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 6, 321-328 (2011
29. M. R. Dilworth, I. Andersson, L. J. Renshall, E. Cowley, P. Baker, S. Greenwood, C. P. Sibley, M. Wareing, Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype. PLOS One 8, e77748 (2013
30. L. J. Renshall, M. R. Dilworth, S. L. Greenwood, C. P. Sibley, M. Wareing, In vitro assessment of mouse fetal abdominal aortic vascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R746-R754 (2014
31. A. N. Sferruzzi-Perri, J. A. Owens, K. G. Pringle, J. S. Robinson, C. T. Roberts, Maternal insulinlike growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology 147, 3344-3355 (2006
32. A. E. Sutherland, P. G. Calarco, C. H. Damsky, Developmental regulation of integrin expression at the time of implantation in the mouse embryo. Development 119, 1175-1186 (1993
33. O. A. Vanderpuye, C. A. Labarrere, J. A. McIntyre, A vitronectin-receptor-related molecule in human placental brush border membranes. Biochem. J. 280, 9-17 (1991
34. Y. Zhou, S. J. Fisher, M. Janatpour, O. Genbacev, E. Dejana, M. Wheelock, C. H. Damsky, Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J. Clin. Invest. 99, 2139-2151 (1997
35. V. Fogal, L. Zhang, S. Krajewski, E. Ruoslahti, Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res. 68, 7210-7218 (2008
36. P. Matos, J. A. Horn, F. Beards, S. Lui, M. Desforges, L. K. Harris, A role for themitochondrial-Associated protein p32 in regulation of trophoblast proliferation. Mol. Hum. Reprod. 20, 745-755 (2014
37. D. M. Waisman, B. P. Salimath, M. J. Anderson, Isolation and characterization of CAB-63, a novel calcium-binding protein. J. Biol. Chem. 260, 1652-1660 (1985
38. M. Michalak, J. Groenendyk, E. Szabo, L. I. Gold, M. Opas, Calreticulin, a multi-process calciumbuffering chaperone of the endoplasmic reticulum. Biochem. J. 417, 651-666 (2009
39. M. G. Coppolino, M. J. Woodside, N. Demaurex, S. Grinstein, R. St-Arnaud, S. Dedhar, Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 386, 843-847 (1997
40. M. Obeid, A. Tesniere, F. Ghiringhelli, G. M. Fimia, L. Apetoh, J.-L. Perfettini, M. Castedo, G. Mignot, T. Panaretakis, N. Casares, D. Métivier, N. Larochette, P. van Endert, F. Ciccosanti, M. Piacentini, L. Zitvogel, G. Kroemer, Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54-61 (2007
41. L. Senovilla, I. Vitale, I. Martins, M. Tailler, C. Pailleret, M. Michaud, L. Galluzzi, S. Adjemian, O. Kepp, M. Niso-Santano, S. Shen, G. Mariño, A. Criollo, A. Boilève, B. Job, S. Ladoire, F. Ghiringhelli, A. Sistigu, T. Yamazaki, S. Rello-Varona, C. Locher, V. Poirier-Colame, M. Talbot, A. Valent, F. Berardinelli, A. Antoccia, F. Ciccosanti, G. M. Fimia, M. Piacentini, A. Fueyo, N. L. Messina, M. Li, C. J. Chan, V. Sigl, G. Pourcher, C. Ruckenstuhl, D. Carmona-Gutierrez, V. Lazar, J. M. Penninger, F. Madeo, C. López-Otín, M. J. Smyth, L. Zitvogel, M. Castedo, G. Kroemer, An immunosurveillance mechanism controls cancer cell ploidy. Science 337, 1678-1684 (2012
42. K. Burns, B. Duggan, E. A. Atkinson, K. S. Famulski, M. Nemer, R. C. Bleackley, M. Michalak, Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367, 476-480 (1994
43. W.-F. Chiang, T.-Z. Hwang, T.-C. Hour, L.-H. Wang, C.-C. Chiu, H.-R. Chen, Y.-J. Wu, C.-C. Wang, L.-F. Wang, C.-Y. Chien, J.-H. Chen, C.-T. Hsu, J. Y.-F. Chen, Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Oral Oncol. 49, 534-541 (2013
44. Z. Shi, W. Hou, X. Hua, X. Zhang, X. Liu, X. Wang, Overexpression of calreticulin in preeclamptic placentas: Effect on apoptosis, cell invasion and severity of pre-eclampsia. Cell Biochem. Biophys. 63, 183-189 (2012
45. T. Teesalu, K. N. Sugahara, V. R. Kotamraju, E. Ruoslahti, C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. U.S.A. 106, 16157-16162 (2009
46. T. Teesalu, K. N. Sugahara, E. Ruoslahti, Mapping of vascular ZIP codes by phage display. Methods Enzymol. 503, 35-56 (2012
47. J.-H. Park, G. von Maltzahn, L. Zhang, A. M. Derfus, D. Simberg, T. J. Harris, E. Ruoslahti, S. N. Bhatia, M. J. Sailor, Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small 5, 694-700 (2009
48. L. K. Harris, I. P. Crocker, P. N. Baker, J. D. Aplin, M. Westwood, IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor. Biol. Reprod. 84, 440-446 (2011
49. H. A. Lacey, T. Nolan, S. L. Greenwood, J. D. Glazier, C. P. Sibley, Gestational profile of Na+/H+ exchanger and Cl-/HCO3 - Anion exchanger mRNA expression in placenta using real-Time QPCR. Placenta 26, 93-98 (2005
50. X. Yue, H. Wang, F. Zhao, S. Liu, J. Wu, W. Ren, Y. Zhu, Hepatitis B virus-induced calreticulin protein is involved in IFN resistance. J. Immunol. 189, 279-286 (2012
51. J. D. Glazier, C. J. P. Jones, C. P. Sibley, Purification and Na+ uptake by human placental microvillus membrane vesicles prepared by three different methods. Biochim. Biophys. Acta 945, 127-134 (1988
52. M. R. Dilworth, L. C. Kusinski, E. Cowley, B. S. Ward, S. M. Husain, M. Constância, C. P. Sibley, J. D. Glazier, Placental-specific Igf2 knockout mice exhibit hypocalcemia and adaptive changes in placental calcium transport. Proc. Natl. Acad. Sci. U.S.A. 107, 3894-3899 (2010
53. M. R. Dilworth, L. C. Kusinski, B. C. Baker, L. J. Renshall, S. L. Greenwood, C. P. Sibley, M. Wareing, Defining fetal growth restriction in mice: A standardized and clinically relevant approach. Placenta 32, 914-916 (2011